Clin Endosc.  2018 Jul;51(4):315-316. 10.5946/ce.2018.122.

Age is Important, but Patient Status is also Important in Endoscopic Retrograde Cholangiopancreatography

• Lee DW
• Kim HG

• KMID: 2419700
• DOI: http://doi.org/10.5946/ce.2018.122

Abstract

No abstract available.

MeSH Terms

Cholangiopancreatography, Endoscopic Retrograde*
Humans

Reference

1. Harness JK, Strodel WE, Talsma SE. Symptomatic biliary tract disease in the elderly patient. Am Surg. 1986; 52:442–445.

2. Farrell RJ, Mahmud N, Noonan N, Kelleher D, Keeling PW. Diagnostic and therapeutic ERCP: a large single centre’s experience. Ir J Med Sci. 2001; 170:176–180.

3. Yun DY, Han J, Oh JS, Park KW, Shin IH, Kim HG. Is endoscopic retrograde cholangiopancreatography safe in patients 90 years of age and older? Gut Liver. 2014; 8:552–556.

4. Sugiyama M, Atomi Y. Endoscopic sphincterotomy for bile duct stones in patients 90 years of age and older. Gastrointest Endosc. 2000; 52:187–191.

5. Katsinelos P, Paroutoglou G, Kountouras J, Zavos C, Beltsis A, Tzovaras G. Efficacy and safety of therapeutic ERCP in patients 90 years of age and older. Gastrointest Endosc. 2006; 63:417–423.

6. Hu L, Sun X, Hao J, et al. Long-term follow-up of therapeutic ERCP in 78 patients aged 90 years or older. Sci Rep. 2014; 4:4918.

7. Sobani ZA, Yunina D, Abbasi A, et al. Endoscopic retrograde cholangiopancreatography in nonagenarian patients: is it really safe? Clin Endosc. 2018; 51:375–380.

8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373–383.

9. Sarfati D, Tan L, Blakely T, Pearce N. Comorbidity among patients with colon cancer in New Zealand. N Z Med J. 2011; 124:76–88.

10. Mnatzaganian G, Ryan P, Norman PE, Hiller JE. Accuracy of hospital morbidity data and the performance of comorbidity scores as predictors of mortality. J Clin Epidemiol. 2012; 65:107–115.

11. West DW, Satariano WA, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996; 6:413–419.

12. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003; 56:221–229.

13. Chen YY, Yen HH, Soon MS. Impact of endoscopy in the management of duodenal diverticular bleeding: experience of a single medical center and a review of recent literature. Gastrointest Endosc. 2007; 66:831–835.

14. Afridi SA, Fichtenbaum CJ, Taubin H. Review of duodenal diverticula. Am J Gastroenterol. 1991; 86:935–938.

15. Boix J, Lorenzo-Zúñig V, Añaños F, Domènech E, Morillas RM, Gassull MA. Impact of periampullary duodenal diverticula at endoscopic retrograde cholangiopancreatography: a proposed classification of periampullary duodenal diverticula. Surg Laparosc Endosc Percutan Tech. 2006; 16:208–211.

16. Grönroos JM, Salminen P, Laine S, Gullichsen R. Feasibility of ERCP procedures in patients 90 years of age and older. J Clin Gastroenterol. 2010; 44:227–228.

17. Mitchell RM, O’Connor F, Dickey W. Endoscopic retrograde cholangiopancreatography is safe and effective in patients 90 years of age and older. J Clin Gastroenterol. 2003; 36:72–74.